
(L-R): Colm Murphy, CTO, NeuroBell; Olive O'Driscoll, Chairperson, NeuroBell; Dr Alison O'Shea, CSO, NeuroBell; Dara O'Shea, Senior Investment Associate, Elkstone; and Dr Mark O'Sullivan, CEO, NeuroBell. Image by UCC.
UCC spin-out secures €4.8 million for US expansion